Effects of lixisenatide on elevated liver transaminases: systematic review with individual patient data meta-analysis of randomised controlled trials on patients with type 2 diabetes

    54 Citationer (Scopus)

    Abstract

    OBJECTIVE: To evaluate the effects of the glucagon-like peptide-1 receptor agonist lixisenatide on elevated liver blood tests in patients with type 2 diabetes.

    DESIGN: Systematic review.

    DATA SOURCES: Electronic and manual searches were combined.

    STUDY SELECTION: Randomised controlled trials (RCTs) on lixisenatide versus placebo or active comparators for type 2 diabetes were included.

    PARTICIPANTS: Individual patient data were retrieved to calculate outcomes for patients with elevated liver blood tests.

    MAIN OUTCOME MEASURES: Normalisation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST).

    DATA SYNTHESIS: The results of included trials were combined in meta-analyses. Sequential, subgroup and regression analyses were performed to evaluate heterogeneity and bias.

    RESULTS: We included 12 RCTs on lixisenatide versus placebo and 3 RCTs with the active comparators liraglutide, exenatide or sitagliptin. The mean treatment duration was 29 weeks. Lixisenatide increased the proportion of patients with normalisation of ALT (risk difference: 0.07; 95% CI 0.01 to 0.14; number needed to treat: 14 patients, p=0.042). The effect was not confirmed in sequential analysis. No effects of lixisenatide were identified on AST, alkaline phosphatase or bilirubin. No evidence of bias was identified. Mixed effect multilevel meta-regression analyses suggest that the benefit of lixisenatide on ALT was limited to patients who were overweight or obese.

    CONCLUSIONS: This review suggests that lixisenatide increases the proportion of obese or overweight patients with type 2 diabetes who achieve normalisation of ALT. Additional research is needed to determine if the findings translate to clinical outcome measures.

    TRIAL REGISTRATION NUMBER: PROSPERO; CRD42013005779.

    OriginalsprogEngelsk
    TidsskriftB M J Open
    Vol/bind4
    Udgave nummer12
    Sider (fra-til)e005325
    ISSN2044-6055
    DOI
    StatusUdgivet - 2014

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Effects of lixisenatide on elevated liver transaminases: systematic review with individual patient data meta-analysis of randomised controlled trials on patients with type 2 diabetes'. Sammen danner de et unikt fingeraftryk.

    Citationsformater